20 Years with SGBS cells - a versatile in vitro model of human adipocyte biology

Int J Obes (Lond). 2022 Nov;46(11):1939-1947. doi: 10.1038/s41366-022-01199-9. Epub 2022 Aug 19.

Abstract

20 years ago, we described a human cell strain derived from subcutaneous adipose tissue of an infant supposed to have Simpson-Golabi-Behmel Syndrome (SGBS), thus called "SGBS cells". Since then, these cells have emerged as the most commonly used cell model for human adipogenesis and human adipocyte biology. Although these adipocyte derived stem cells have not been genetically manipulated for transformation or immortalization, SGBS cells retain their capacity to proliferate and to differentiate into adipocytes for more than 50 population doublings, providing an almost unlimited source of human adipocyte progenitor cells. Original data obtained with SGBS cells led to more than 200 peer reviewed publications comprising investigations on adipogenesis and browning, insulin sensitivity, inflammatory response, adipokine production, as well as co-culture models and cell-cell communication. In this article, we provide an update on the characterization of SGBS cells, present basic methods for their application and summarize results of a systematic literature search on original data obtained with this cell strain.

Publication types

  • Review
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adipocytes*
  • Adipokines
  • Biology
  • Gigantism*
  • Humans
  • Infant

Substances

  • Adipokines

Supplementary concepts

  • Simpson-Golabi-Behmel syndrome